Navigation Links
'Smart' genetic therapy helps the body to heal itself

New approaches to genetic disease, based on cells' own ability to correct themselves, will be outlined today (Monday 8 May 2006) at the annual conference of the European Society of Human Genetics in Amsterdam, The Netherlands. Instead of replacing a faulty gene (commonly referred to as gene therapy) these new 'smart' approaches make use of the therapeutic potential that already exists in human biology.

Professor Brunhilde Wirth, from the Institute of Human Genetics, University of Cologne, Germany, will describe to the conference her team's work on developing therapies for patients with spinal muscular atrophy (SMA). This is a relatively common inherited disease in humans and the leading cause of death in infants, with an incidence of about 1 in every 6,000 newborns. Due to degeneration of the motor neurons in the spinal cord patients develop muscle weakness and atrophy of the legs, arms and trunk.

In patients with SMA the survival motor neuron genes (SMN1) is deleted, but they all carry a copy gene (SMN2). However, this only produces about 10% of the correct protein; insufficient to prevent the diseases. The severity of the SMA is influenced by the number of SMN2 genes, which normally vary between one and four ?the more copies there are the better the patient does.

Professor Wirth's team identified a drug ?valproate, used successfully in epilepsy treatment for decades ?that is able to increase SMN protein levels 2-4 fold in cell lines derived from SMA patients. Later, they showed that valproate also raised SMN levels in neuronal tissues such as cultured brain slices derived from epilepsy patients after surgery, as well as motor neuron cultures derived from rat embryos.

"The next step was to try this therapy in patients", said Professor Wirth. "In a first pilot trial, we enrolled ten parents of SMA patients who were treated with valproate for four months. We saw that valproate significantly increased SMN levels in blo
'"/>

Source:European Society of Human Genetics


Page: 1 2 3 4

Related biology news :

1. Smart nanoprobes light up disease
2. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
3. Scientists detect probable genetic cause of some Parkinsons disease cases
4. Mouse brain tumors mimic those in human genetic disorder
5. Scientists identify genetic pathways essential to RNA interference
6. Researchers trace evolution to relatively simple genetic changes
7. Key mechanism in genetic inheritance during cell division identified
8. Scientists identify genetic pathways essential to RNA interference
9. MUHC scientists describe genetic resistance to rampant virus
10. Mosaic mouse technique offers a powerful new tool to study diseases and genetics
11. Montreal researchers probe the genetic basis of memory

Post Your Comments:
(Date:11/25/2009)...University assistant professors recently received ... to continue research beneficial to understanding ..., Christopher Blackwood, assistant professor in ... grants to support two separate research projects....Decomposer Communities and Functions from the Leaf...
(Date:11/24/2009)...f years it has been prescribed by traditional heal...adaches and stomach pain to fever and flu. , Now ...rsity have been able to scientifically prove the p...rwise known as Brazilian mint. , Testing this anc...researcher Graciela Rocha was able to show that wh...
(Date:11/24/2009)...is opening new doors to understanding how sounds a... of a marine mammal or if they hear it at all. ,...anners that NASA uses to detect flaws in the space...wing scientists to peek inside the giant head of a...ensional replicas of a whale,s hearing anatomy usi...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 50697 1Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 50697 2Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 50697 3Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 50697 4Dr Julian Whitaker Featured on Searchjointpain com 50694 1Dr Julian Whitaker Featured on Searchjointpain com 50694 2ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 1ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 2ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 3ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 4ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 5
...p an onion and you risk crying over your cutting b...nd nose. Scientists do not know why certain chemic...re so highly irritating, but new research in mice ...l cavity cells. Researchers funded by the National...orders (NIDCD), part of the National Institutes of...
... living in the oceans play a critical role in regu...n about their activities and how they work togethe...and energy. , A team of MIT researchers led by P...ng to change that. , Borrowing gene sequencing ...he researchers have devised a new method to analyz...
...percent of the worlds carbonmore than the atmosphe...rbon dynamics to predict whether anthropogenic glo... pools. Helene Muller-Landau, staff scientist at t...ced a major global research effort to quantify for... effort at the Climate Change in the Americas Symp...
Other Biology News:Irritating smells alert special cells, NIH-funded study finds 2Irritating smells alert special cells, NIH-funded study finds 3Team probes mysteries of oceanic bacteria 2Smithsonian announces Global Forest Carbon Research Initiative 2
(Date:11/24/2009)... , SAN MATEO, Calif., Nov. 24 /PRNewswire... biopharmaceutical company focused on developing a..., announced today that Anthony DiTonno, President ...nt at the 21st Annual Piper Jaffray Health Care Co... York Palace Hotel in New York, New York. ,, M...
(Date:11/24/2009)... , SEATTLE, Nov. 24 Blue Marb...nd the Odessa Public Development Authority (OPDA) ...te,s Community Economic Revitalization Board (CERB... state,s first specialty biochemical biorefinery i...l significantly speed the development of our biore...
(Date:11/24/2009)... , , Primary efficacy endpoint has been m...nt endometrial cancer, , QUEBEC CITY, Nov. 24...ASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global...erapy and oncology, today announced positive effic...totoxic peptide conjugate, AEZS-108 (formerly AN-1...
(Date:11/24/2009)... , DUBLIN, November 24 /PRNewswire-First...e global specialty biopharmaceutical company, toda...opean Medicines Agency for,velaglucerase alfa, the...nt,for the treatment of Type 1 Gaucher disease. Th...erase alfa that has been submitted, with previous,...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4
...et Exchange Agreement, COPENHAGEN, September 13 ...n of an asset exchange agreement with,Medarex, Inc...ceive full,rights to HuMax-Inflam(TM)/MDX-018, whi...hts to multiple disease programs in oncology. Genm...iously held economic interests,in the assets excha...
...2 Schering-Plough,Corporation (NYSE: SGP ) annou...ggregate principal amount of 6.00% Senior Notes du...f 6.55% Senior Notes due 2037 through,an underwrit...pected to,close on Sept. 17, 2007, subject to cust...for the offering is Goldman, Sachs & Co. The,joint...
...2 PPD, Inc. (Nasdaq:,PPDI) today announced Daniel...ficer. He will assume his position on October 1. ... Honeywell,International, a $34 billion diversifie...st recently served as vice president and CFO of fi...s at Honeywell, he was CFO of,the company,s global...
Other Biology Technology:Genmab Announces Asset Exchange Agreement 2Schering-Plough Announces Pricing of Senior Notes Offering 2Schering-Plough Announces Pricing of Senior Notes Offering 3PPD Names Daniel Darazsdi as Chief Financial Officer 2PPD Names Daniel Darazsdi as Chief Financial Officer 3
...ed for Optimal Microdissection , CapSure HS and C... extraction of populations of pure cells from tiss...e Microdissection., Ensure the Integrity of Micr... , All CapSure LCM Caps have a patented transfer ...
...n system is used for single-color real-time detect...rophores and features a real-time PCR thermal grad... from 96 wells, a gene expression macro for relati...is. The system includes the optical module and opt...
...ed for Optimal Microdissection , CapSure HS and C... extraction of populations of pure cells from tiss...e Microdissection., Ensure the Integrity of Micr... , All CapSure LCM Caps have a patented transfer ...
DNA Engine Opticon Continuous Fluorescence Detection System from Bio-Rad
Biology Products: